Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net earnings (loss) attributable to Viatris Inc. common shareholders	$ (117.7)	$ 820.3
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Depreciation and amortization	2,147.0	2,096.1
Share-based compensation expense	113.8	124.9
Deferred income tax benefit	(518.7)	(179.9)
Loss on disposal of business	295.8	0.0
Acquired IPR&D	(12.7)	11.3
Other non-cash items	140.4	(52.1)
Litigation settlements and other contingencies, net	245.6	(54.6)
Changes in operating assets and liabilities:
Accounts receivable	(0.4)	(2.8)
Inventories	(687.8)	(485.7)
Accounts payable	(9.7)	236.3
Income taxes	286.9	(29.6)
Other operating assets and liabilities, net	(62.3)	(152.7)
Net cash provided by operating activities	1,820.2	2,331.5
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired	(350.0)	(667.7)
Capital expenditures	(185.6)	(211.5)
Purchase of marketable securities	(21.7)	(20.9)
Proceeds from the sale of marketable securities	21.7	20.9
Payments for product rights and other, net	(20.1)	(62.1)
Refunds (purchases) of IPR&D	12.7	(11.3)
Proceeds from sale of assets and subsidiaries	2,510.2	48.0
Proceeds from the sale of property, plant and equipment	2.2	13.4
Net cash provided by (used in) investing activities	1,969.4	(891.2)
Cash flows from financing activities:
Payments of long-term debt	(2,339.4)	(750.1)
Purchase of common stock	(250.0)	(250.0)
Change in short-term borrowings, net	1.5	0.2
Taxes paid related to net share settlement of equity awards	(53.3)	(32.6)
Contingent consideration payments	(31.5)	(8.4)
Payments of financing fees	(4.8)	(0.3)
Cash dividends paid	(431.5)	(431.6)
Non-contingent payments for product rights	0.0	(9.7)
Issuance of common stock	1.9	2.5
Other items, net	196.9	104.2
Net cash used in financing activities	(2,910.2)	(1,375.8)
Effect on cash of changes in exchange rates	7.1	(15.2)
Net increase in cash, cash equivalents and restricted cash	886.5	49.3
Cash, cash equivalents and restricted cash — beginning of period	993.6	1,262.5
Cash, cash equivalents and restricted cash — end of period	$ 1,880.1	$ 1,311.8